Nano Medicine and Nano Safety : Recent Trends and Clinical Evidences (2020)

個数:

Nano Medicine and Nano Safety : Recent Trends and Clinical Evidences (2020)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 635 p.
  • 言語 ENG
  • 商品コード 9789811562570
  • DDC分類 610.28

Full Description

This book reviews the application of Nanobiotechnology in the development of Nanomedicine, while also discussing the latest trends and challenges in the clinical translation of Nanomedicine. Nanomedicine refers to the application of Nanotechnology to medicine and holds tremendous potential for achieving improved efficiency, bioavailability, dose response, personalized medicine and enhanced safety as compared to conventional medicines.

The book first introduces readers to the basic concepts of Nanomedicine, and to technological advances in and applications of Nanotechnology in treatment, diagnosis, monitoring, and drug delivery. In turn, it reviews the current status of multi-functionalization strategies for using Nanoparticles in the targeted delivery of therapeutic agents. The book's third and final section focuses on the regulatory and safety challenges posed by Nanomedicine, including industry and regulatory agencies' efforts to address them.

Contents

Part A: Applications of Nano Biotechnology in the development of Nano Medicine.- Chapter 1. Nanobiotechnology and its application in Nanomedicine: An Overview.- Chapter 2. Nanobiotechnology for therapeutic targeting of circulating tumor cells in the blood.- Chapter 3. Application of Nanobiotechnology in clinical diagnosis.- Chapter 4. Anti-diabetic Nano formulation from herbal source.- Chapter 5. Nanomaterials for alternative antibiotic therapy.- Part B: Nano Medicine: concept, development, clinical applications and evidences.- Chapter 6. Nano medicines and Nano drug delivery systems: trends and perspectives.- Chapter 7. Nano medicines in drug delivery from synthetic/natural sources to their clinical applications.- Chapter 8. Transdermal Nanomedicines for Reduction of Dose And Site-Specific Drug Delivery.- Chapter 9. Multifunctional mesoporous silica nanoparticles for biomedical applications.- Chapter 10. Advances in pulmonary Nano medicine for therapeutic management of respiratory diseases.- Chapter 11. Nanoemulsion Delivery of Herbal Products: Prospects and Challenges.- Chapter 12. Stimuli-responsive polymers for cancer Nano medicines.- Chapter 13. Carbohydrate-Derived Tailorable Interfaces: Recent Advances and Applications.- Chapter 14. Multifunctional Nano scale particles for theranostic application in healthcare.- Chapter 15. Ligand nanoparticle conjugation approach for targeted cancer chemotherapy.- Chapter 16. Tunable Biopolymeric Drug Carrier Nanovehicles and Their Safety.- Chapter 17. Nano medicine for challenging solid tumors: Recent trends and future ahead.- Part C: Regulatory, safety and marketing aspects of Nano Medicine.- Chapter 18. Recent trends for Nano medicine safety.- Chapter 19. Nano toxicity and risk assessment of Nano medicines.- Chapter 20. Clinical toxicity of Nano medicines.- Chapter 21. Nano Medicine: Risk, Regulation, Safety and Public Health.- Chapter 22. New deliveries and nanomedicines: Commercial aspects and business perspectives.- Chapter 23. Global growth of Nano medicines and what role it will play for economically weak countries.

最近チェックした商品